Back to Search
Start Over
Reply
- Source :
- Journal of the American College of Cardiology. 73:2360
- Publication Year :
- 2019
- Publisher :
- Elsevier BV, 2019.
-
Abstract
- The COMPASS (Cardiovascular OutcoMes for People Using Anticoagulation StrategieS) coronary artery bypass graft (CABG) substudy [(1)][1] involved only 1,448 patients and clearly was not powered to demonstrate a significant effect of treatment on major adverse cardiovascular events (MACE). However
- Subjects :
- Rivaroxaban
Aspirin
medicine.medical_specialty
medicine.drug_mechanism_of_action
business.industry
Factor Xa Inhibitor
MEDLINE
030204 cardiovascular system & hematology
03 medical and health sciences
0302 clinical medicine
medicine.anatomical_structure
Internal medicine
medicine
Cardiology
Platelet aggregation inhibitor
cardiovascular diseases
030212 general & internal medicine
Cardiology and Cardiovascular Medicine
business
Cardiovascular outcomes
Mace
medicine.drug
Artery
Subjects
Details
- ISSN :
- 07351097
- Volume :
- 73
- Database :
- OpenAIRE
- Journal :
- Journal of the American College of Cardiology
- Accession number :
- edsair.doi...........82e2f2124e3145157a4681c73a1220e8
- Full Text :
- https://doi.org/10.1016/j.jacc.2019.03.022